Cleared Traditional

K972359 - REMEL BILE ESCULIN AZIDE AGAR W/6 MCG/ML VANCOMYCIN
(FDA 510(k) Clearance)

Aug 1997
Decision
64d
Days
Class 2
Risk

K972359 is an FDA 510(k) clearance for the REMEL BILE ESCULIN AZIDE AGAR W/6 MCG/ML VANCOMYCIN. This device is classified as a Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar (Class II - Special Controls, product code JSO).

Submitted by Remel, L.P. (Lenexa, US). The FDA issued a Cleared decision on August 28, 1997, 64 days after receiving the submission on June 25, 1997.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1700.

Submission Details

510(k) Number K972359 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 1997
Decision Date August 28, 1997
Days to Decision 64 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code JSO — Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1700